“These companies have reasonably good fundamentals, you don’t have to take out a new mortgage to fill your prescription, they are big, liquid companies…they have robust dividends and then last, but not least, the political will for change is low in terms of these companies.”
Hazlett’s favorite stocks in the sector are Schering-Plough , which he says has no meaningful patent expirations for four to five years, and Bristol-Myers
Bruce Nudell, medical supply analyst at UBS, likes Baxter International, Abbott Labs and Zimmer Holdings .
Caterpillar Profit Disappoints, Keeps Outlook
Buffett's Pro-Stock Stance Backed By Big Short-Seller
Cramer to CEOs: Just Say Yes to Takeovers
More from CNBC.com: